title: Reduction of acquired high titer factor VIII antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy.
authors.forename: M
authors.initials: M
authors.lastname: Toepfer
authors.forename: F
authors.initials: F
authors.lastname: Rommel
authors.forename: T
authors.initials: T
authors.lastname: Sitter
authors.forename: M
authors.initials: M
authors.lastname: Spannagl
authors.forename: E
authors.initials: E
authors.lastname: Held
authors.forename: W
authors.initials: W
authors.lastname: Schramm
authors.forename: H
authors.initials: H
authors.lastname: Schiffl
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology / Q000302:isolation & purification*; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D003131:Combined Modality Therapy; D005112:Extracorporeal Circulation; D005169:Factor VIII / Q000276:immunology*; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged
chemical_list: D000888:Antibodies, Anti-Idiotypic; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D005169:Factor VIII